Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Sandoz

Product Description

Sandoz is a world leading manufacturer of biotechnological products. Our expertise stems from decades of experience in this complex field, particularly in the production of intermediates for third parties. Early successes were marked by the production of the first-ever oral penicillin in 1951 (anti-infectives), and one of the first recombinant proteins, an interferon, in 1980 (biopharmaceuticals).

Over the years, our role has evolved from simply a contract manufacturer to a full-service provider, i.e. providing solutions for all steps in the value chain of a project through to building strong relationships with our partners. Underlying this role is trust – trust in the shared values of a global company, trust in the innovative solutions we provide, and trust in the quality of our products and services on the back of our long history and industry know-how.

Sandoz has traditionally been among the leading specialists in microbial fermentation of classic and recombinant microorganisms. Our comprehensive know-how is based on several decades of experience in the fields of classical microbial products and recombinant microbial production at a commercial scale. In 2004, we successfully extended our production technology into the field of mammalian cell culture.

Today, we are a fully integrated manufacturer of recombinant products. We provide customized solutions for our partners that span the entire value chain, from development to production and fill and finish to customers. The flexibility in production capabilities to fully integrated services offers a variety of options when it comes to scaling different phases of development and commercial manufacturing, furthering the cost advantage to customers.

Sandoz is currently engaged in biotech cooperations with a number of leading organizations and continuously looks to extend its number of partnerships in the future. This strong experience combined with a successful track record of accomplishments and state-of-the-art plants, offers a unique opportunity to partners interested in pursuing manufacturing cooperations.

Product Sandoz
Company Sandoz
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Sandoz
Industriestrasse 25 83607 Holzkirchen Germany

Tel: +49 (0) 8024 476-0
Fax: +49 (0) 8024 476-2599
Email: info.sandoz@sandoz.com



Scientific News
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!